Literature DB >> 26122102

Antibacterial and antibiotic resistance modifying activity of the extracts from Allanblackia gabonensis, Combretum molle and Gladiolus quartinianus against Gram-negative bacteria including multi-drug resistant phenotypes.

Aimé G Fankam1, Jules R Kuiate2, Victor Kuete3.   

Abstract

BACKGROUND: Bacterial resistance to antibiotics is becoming a serious problem worldwide. The discovery of new and effective antimicrobials and/or resistance modulators is necessary to tackle the spread of resistance or to reverse the multi-drug resistance. We investigated the antibacterial and antibiotic-resistance modifying activities of the methanol extracts from Allanblackia gabonensis, Gladiolus quartinianus and Combretum molle against 29 Gram-negative bacteria including multi-drug resistant (MDR) phenotypes.
METHODS: The broth microdilution method was used to determine the minimal inhibitory concentrations (MIC) and minimal bactericidal concentrations (MBC) of the samples meanwhile the standard phytochemical methods were used for the preliminary phytochemical screening of the plant extracts.
RESULTS: Phytochemical analysis showed the presence of alkaloids, flavonoids, phenols and tannins in all studied extracts. Other chemical classes of secondary metabolites were selectively presents. Extracts from A. gabonensis and C. molle displayed a broad spectrum of activity with MICs varying from 16 to 1024 μg/mL against about 72.41% of the tested bacteria. The extract from the fruits of A. gabonensis had the best activity, with MIC values below 100 μg/mL on 37.9% of tested bacteria. Percentages of antibiotic-modulating effects ranging from 67 to 100% were observed against tested MDR bacteria when combining the leaves extract from C. molle (at MIC/2 and MIC/4) with chloramphenicol, kanamycin, streptomycin and tetracycline.
CONCLUSION: The overall results of the present study provide information for the possible use of the studied plant, especially Allanblackia gabonensis and Combretum molle in the control of Gram-negative bacterial infections including MDR species as antibacterials as well as resistance modulators.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26122102      PMCID: PMC4487221          DOI: 10.1186/s12906-015-0726-0

Source DB:  PubMed          Journal:  BMC Complement Altern Med        ISSN: 1472-6882            Impact factor:   3.659


Background

Infectious diseases caused by multi-drug resistant (MDR) Gram-negative bacteria are worldwide health concern, causing increasingly morbidity and mortality particularly in developing countries [1]. In Cameroon, previous studies showed high levels of resistance to commonly used antibiotics in Gram-negative bacilli [2]. Several reports also mentioned an increase in the hospital dissemination of bacterial strains specifically those expressing drug efflux mechanism [3, 4]. Against Gram-negative bacteria, the discovery of efflux pump inhibitors (EPIs) is an attractive strategy to combat MDR phenotypes [5]. EPI generally interact with specific efflux pump proteins to restore the susceptibility of MDR bacteria to antibiotics [6]. Medicinal plants constitute an important source of chemotherapeutic molecules, in regards to the chemical diversity found in several species [7, 8]. In recent years, some plants have been successfully evaluated for their direct antibacterial action, and for their antibiotic-modulation activity [9-12]. In the present work, we hypothesized that herbal medicines traditionally used for the treatment of infectious diseases could contain molecules acting as antibacterial and/or antibiotic-resistance modulators. This study was therefore designed to investigate the in vitro antibacterial and antibiotic-resistance modifying activities of the methanol extracts from Allanblackia gabonensis Pellegr. (Clusiaceae), Gladiolus quartinianus A. Rich (Iridaceae) and Combretum molle R. Br. ex G. Don (Combretaceae) against Gram-negative bacteria including multi-drug phenotypes. These plants are traditionally used to manage various ailments including bacterial related infections.

Methods

Plant materials and extraction

Medicinal plants used in this work were collected in different areas of Cameroon between January and April 2012. The plants were identified at the National Herbarium (Yaoundé, Cameroon), where voucher specimens were deposited under the reference numbers (Table 1). The air-dried and powdered plant material was weighed (300 g) and soaked in 1 L of methanol (MeOH) for 48 h at room temperature. The filtrate obtained through Whatman filter paper No. 1 was concentrated under reduced pressure in vacuum to obtain the crude extracts. All crude extracts were then kept at 4 °C until further uses.
Table 1

Plants used in the present study and evidence of their bioactivities

Samples, family, and herbarium number a Traditional treatment Area of plant collection Known bioactive or potentially active compounds Screened biological activities of the crude extracts and known bioactive compounds
Allanblackia gabonensis Pellegr. (Clusiaceae); 17275SRF/CamDysentery, cold, toothache [13]; pain, rheumatism, inflammations [14, 15].Lebialem, South West region of Cameroon; (4°10′N 9°14′E/4.167°N 9.233°E)Not reportedCrude extracts: Analgesic and anti-inlammatory effect of aqueous extract of the stem bark [14]; crude methanol fruits extracts (40 μg/mL) showed to inhibit growth of CCRF-CEM leukemia cells at about 50 % [16].
Gladiolus quartinianus A. Rich (Iridaceae); 17260/SRF/CamInfections of the skin, gut, urogenital system, and upper respiratory tract [17], gonorrhea, infectious conditions, constipation and dysentery [18].Lebialem, South-West region of Cameroon; (4°10′N 9°14′E/4.167°N 9.233°E)Not reportedMethanol crude extract was reported to possess moderate to significant anticancer activity (IC50: 29.60 to10.57 μg/mL) against drug-resistance cancer cell lines [16]
Combretum molle R. Br. ex G. Don (Combretaceae); 33311/ HNCFever, abdominal pains, convulsion, worm infections, human immunodeficiency virus (HIV)/acquiredimmune deficiency syndrome (AIDS) related infections [19]; hookworm, snake bite, leprosy, dysentery, general body swellings, arthritic and other inflammatory conditions, sterility, constipation [20, 21]; Parasitic, protozoan, infectious diseases [22], malaria [23]University of Dschang, West region of Cameroon; (6°30′N 10°30′E/6.500°N 10.500°E)Mollic acid glucoside [21]); β-D-glucopyranosyl 2α,3β,6β-trihydroxy-23-galloylolean-12-en-28-oate,combregenin, arjungenin, arjunglucoside I, and combreglucoside [24] .Crude extracts were evaluated for: antibacterial activity [2527]; antimycobacterial [28]; antifungal effects [29]; antimalarial [30]; anthelmintic activities [31]; anti-HIV by inhibition of ribonuclease-H [19]; Cytotoxic effects against T-24 bladder cancer cells [32]; Anti-inflammatory activity [24]; in vitro anticholinesterase and inhibitory effects on Rabbit Breathing [33]. Compounds: mollic acid glucoside (MAG) showed analgesic, anti-inflammatory properties in mice and rats [21], cardiovascular effect [34]; hypoglycaemic effect [35]; Punicalgin and CM-A, two isolated tannins were assessed for their anti-HIV activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) [36].

aPlants were identified at the Cameroon National Herbarium (HNC)

Plants used in the present study and evidence of their bioactivities aPlants were identified at the Cameroon National Herbarium (HNC)

Chemicals for antibacterial assays

Eight commonly used antibiotics including tetracycline (TET), kanamycin (KAN), streptomycin (STR), ciprofloxacin (CIP), norfloxacin (NOR), chloramphenicol (CHL), ampicillin (AMP), erythromycin (ERY) (Sigma-Aldrich, St Quentin Fallavier, France) were used. The p-Iodonitrotetrazolium chloride 0.2 % (INT) and phenylalanine arginine β-naphthylamide (PAβN) (Sigma-Aldrich) were used as bacterial growth indicator and efflux pumps inhibitor respectively.

Microorganisms and growth conditions

Pathogenic bacteria used in the study were Gram-negative bacteria including MDR isolates (Laboratory collection) and reference strains (American Type Culture Collection) of Escherichia coli (ATCC8739, ATCC10536, AG100, AG100A, AG100ATet, AG102, MC4100 W3110), Enterobacter aerogenes (ATCC13048, CM64, EA27, EA3, EA289, EA298, EA294), Klebsiella pneumoniae (ATCC11296, KP55, KP63, K24, K2), Enterobacter cloacae (ECCI69, BM47, BM67), Pseudomonas aeruginosa (PA01, PA124) and Providencia stuartii (ATCC29916, NEA16, PS2636, PS299645) were used. Their features were previously reported [37]. They were maintained at 4 °C and sub-cultured on a fresh appropriate Mueller Hinton Agar (MHA) for 24 h before any antibacterial test.

Preliminary phytochemical investigation

The plant extracts were screened for the presence of major secondary metabolite classes such as alkaloids, anthocyanins, anthraquinones, flavonoids, phenols, saponins, sterols and triterpenes according to common phytochemical methods previously described [38]. The tests were based on visual observation of the change in color or formation of precipitate after the addition of specific reagents.

Antibacterial assays

MICs and MBCs of the plant extracts and chloramphenicol were determined by microdilution method using rapid INT colorimetric assay [25, 39]. Briefly, the samples were first dissolved in 10 % Dimethyl-sulfoxide (DMSO)/Mueller Hinton Broth (MHB). The solution obtained was then added to MHB and serially diluted two fold (in a 96-well microplate). One hundred microliters of inoculum (1.5× 106 CFU/mL) prepared in MHB were then added. The plates were covered with a sterile plate sealer and then agitated with a shaker to mix the contents of the wells and incubated at 37 °C for 18 h. The final concentration of DMSO was less than 2.5 %, and did not affect the microbial growth. Wells containing MHB, 100 μL of inoculum, and DMSO at a final concentration of 2.5 % served as the negative control. The MIC of each sample was detected after 18 h of incubation at 37 °C following addition of 40 μL INT (0.2 mg/mL) and incubation at 37 °C for 30 min. Viable bacteria reduced the yellow dye to a pink. The MIC was defined as the lowest sample concentration that prevented this change and that resulted in the complete inhibition of bacterial growth. The MBC of the sample was determined by sub-culturing 50 μL of the suspensions from the wells which did not show any growth after incubation during MIC assays to 150 μl of fresh broth, and re-incubated at 37 °C for 48 h before revelation. The MBC was defined as the lowest concentration of sample which completely inhibited the growth of bacteria [40]. Each assay was performed in three independent tests in triplicate. The samples were also tested in the presence of phenylalanine arginine β-naphthylamide (PAβN) at a final concentration of 20 μg/mL as previously described [41] on nine MDR bacteria. All assays were performed three time in duplicate.

Antibiotic-modulation assay

To evaluate the antibiotic resistance modifying activity of the extracts, the MIC of antibiotic was determined in the presence or absence of the plant extracts. The 96-wells plate modulation method, as described by Stavri et al. [42] was used. Briefly, after serial dilutions of antibiotics (256–0.5 μg/mL), the plant extracts at their sub-inhibitory concentrations (MIC/2 and MIC/4; selected after preliminary study; Table 2), were added and inoculation was done. The MIC was determined as described above. Modulation factors (MF), calculated as MIC Antibiotic alone/MIC Antibiotic alone + Extract; was used to express the modulating or synergy effects of the plant extracts.
Table 2

MIC of antibiotics in combination with extracts at sub-inhibitory concentrations against P. aeruginosa PA124

Plant extracts a Antibiotcs b
CHL AMP ERY KAN STR TET CIP NFX
ATB Alone64-128128641632128
AGRMIC/264(1)- (NA)128(1)16(2) 32(2)16(1)32(1)128(1)
MIC/464(1)- (NA)128(1)16(2)64(1)16(1)32(1)128(1)
MIC/864(1)- (NA)128(1)128(1)64(1)16(1)32(1)128(1)
MIC/1664(1)- (NA)128(1)128(1)64(1)16(1)32(1)128(1)
AGBMIC/264(1)- (NA)128(1)128(1)32(2) 8(2) 32(1)128(1)
MIC/464(1)- (NA)128(1)128(1)64(1)16(1)32(1)128(1)
MIC/864(1)- (NA)128(1)128(1)64(1)16(1)32(1)128(1)
MIC/1664(1)- (NA)128(1)128(1)64(1)16(1)32(1)128(1)
AGLMIC/264(1)- (NA)128(1)16(2) 64(1)16(1)32(1)128(1)
MIC/464(1)- (NA)128(1)128(1)64(1)16(1)32(1)128(1)
MIC/864(1)- (NA)128(1)128(1)64(1)16(1)32(1)128(1)
MIC/1664(1)- (NA)128(1)128(1)64(1)16(1)32(1)128(1)
AGF MIC/2 32(2) - (NA)128(1)64(2) 32(2) 16(1)32(1)128(1)
MIC/4 64(1)- (NA)128(1)64(2) 32(2) 16(1)32(1)128(1)
MIC/864(1)- (NA)128(1)64(2)64(1)16(1)32(1)128(1)
MIC/1664(1)- (NA)128(1)64(2) 64(1)16(1)32(1)128(1)
AGFlMIC/264(1)- (NA)128(1)64(2) 64(1)8(2) 32(1)128(1)
MIC/464(1)- (NA)128(1)64(2) 64(1)16(1)32(1)128(1)
MIC/864(1)- (NA)128(1)64(2) 64(1)16(1)32(1)128(1)
MIC/1664(1)- (NA)128(1)12864(1)16(1)32(1)128(1)
GQWMIC/264(1)- (NA)128(1)64(2) 32(2) 16(1)32(1)128(1)
MIC/464(1)- (NA)128(1)64(2) 64(1)16(1)32(1)128(1)
MIC/864(1)- (NA)128(1)12864(1)16(1)32(1)128(1)
MIC/1664(1)- (NA)256(0.5)12864(1)16(1)32(1)128(1)
CML MIC/2 32(2) - (NA)64(2) 64(2) 32(2) 4(4) 16(2) 16(2)
MIC/4 32(2) - (NA)64(2) 64(2) 32(2) 4(4) 16(2) 16(2)
MIC/864(1)- (NA)128(−)64(2) 64(1)8(2) 32(1)128(1)
MIC/16641)- (NA)128(−)64(2) 64(1)8(2) 32(1)128(1)

: Plan extracts: (AGFl : Allanblackia gabonensis Flowers, AGF : Allanblackia gabonensis Fruits, AGL: Allanblackia gabonensis Leaves, AGB: Allanblackia gabonensis Stem barks, AGR: Allanblackia gabonensis Root barks, GQW: Gladiolus quartinianus Whole plant, CML: Combretum molle Leaves); : Antibiotics (TET: tetracycline, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin); − : MIC not detected at up to 256 μg/mL; (): Modulation factor or gain of activity; NA: Not applicable, Values in bold represent the modulation factor ≥ 2, the selected extracts and its concentrations to be used on others MDR bacteria

MIC of antibiotics in combination with extracts at sub-inhibitory concentrations against P. aeruginosa PA124 : Plan extracts: (AGFl : Allanblackia gabonensis Flowers, AGF : Allanblackia gabonensis Fruits, AGL: Allanblackia gabonensis Leaves, AGB: Allanblackia gabonensis Stem barks, AGR: Allanblackia gabonensis Root barks, GQW: Gladiolus quartinianus Whole plant, CML: Combretum molle Leaves); : Antibiotics (TET: tetracycline, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin); − : MIC not detected at up to 256 μg/mL; (): Modulation factor or gain of activity; NA: Not applicable, Values in bold represent the modulation factor ≥ 2, the selected extracts and its concentrations to be used on others MDR bacteria

Results

Phytochemical Screening of the plant extracts

The main classes of secondary metabolites for each extract were screened and the results are summarized in Table 3. Tannins, flavonoids, alkaloids and phenols were present in all tested extracts. Others classes of botanicals were selectively distributed in different plant extracts.
Table 3

Qualitative phytochemical composition of the plant extracts

Plant samples Phytochemical composition
Triterpenes Flavonoids Alkaloids Anthraquinones Phenols Anthocyanines Saponins Tannins Steroids
Allanblackia gabonensis -+ + +++_ + -
-++-++-+-
++++++++-
++++++++-
+++-++++-
Gladiolus quartinianus +++ - ++-++
Combretum molle -++-+-+++

(+): present; (−): absent

Qualitative phytochemical composition of the plant extracts (+): present; (−): absent

Antibacterial activity of the plant extracts

The results summarized in Table 4 show that all extracts were active on at least three of bacterial strains, with MIC values varying from 16 to 1024 μg/mL. Extracts from Combretum molle leaves (CML) and Allanblackia gabonensis displayed the most important spectrum of activity. Their inhibitory effects were observed on 72.41 % (27/29) for CML of the tested bacteria, 58.62 % (17/29) for leaves (AGL), 75.86 % (22/29) for flower (AGFl) and bark (AGB), 79.31 % (23/29) for bark and 86.20 % (25/29) for fruits (AGF) extracts from Allanblackia gabonensis. AGF was the best extract with MIC values below 100 μg/mL on 38 % (11/29) of the tested bacteria. CML mostly showed moderate activity with MIC values ranging from 128–512 μg/mL. The activity of CHL was comparable to that of plant extracts in certain cases. This was the case with AGF, AGFl and AGR against K. pneumoniae Kp55 (64 μg/mL); AGF against K. pneumoniae Kp53 (64 μg/mL), and AGFl against P. stuartii PS2636 (32 μg/mL). MICs values equal or above 1024 μg/mL were obtained with the extract from G. quartinianus (GQW). MBCs values were generally equal or below 1024 μg/mL (Table 4).
Table 4

Minimal inhibitory concentration (MIC) and minimal bactericidal (MBC) of the plant extracts and CHL on the studied bacterial species

Bacteria used Tested samples, MIC and MBC (μg/mL)
Allanblackia gabonensis Gladiolus quartinianus (GQW) Combretum molle (CML) Chloramphenicol
Flowers (AGFl)Fruits (AGF)Leave (AGL)Stem barks (AGB)Root barks (AGR)
MICMBCMICMBCMICMBCMICMBCMICMBCMICMBCMICMBCMICMBC
E. coli
ATCC8739 64 512 16 256512- 64 256 64 2561024-2561024232
ATCC10536 64 512 32 2565121024 32 128 64 2561024-512512132
AG100--1024--1024-512---51210248128
AG100A128512 64 256512512128512128512--51210240.564
AG100ATet 1024-512---1024-1024---1024-64256
AG1021024-1024---1024-1024---1024-32>256
MC41002565121281024512-256512512-1024-256102432>256
W3110256-2565125121024 64 5122561024--51210248128
E. aerogenes
ATCC130481281024 16 1282561024 32 512 32 5121024-1024-864
CM64--1024-------1024->256>256
EA275121024128512512-128512128512--1024102464256
EA31024---1024-512-512---1024-128>256
EA2891024-1024-----1024---1024-128>256
EA2981024----------1024-64>256
EA294128256 64 5122561024 64 51212810241024-1285121664
E. cloacae
ECCI69--1024-----1024----->256>256
BM47--1024---1024------->256>256
BM67------------1024->256>256
K. pneumoniae
ATCC112961281024 16 1282561024 32 256 32 2561024-5121024432
KP55 64 256 64 2561024-2561024 64 512--512102464256
KP63128256 64 2562561024128512128256--512-64256
K24--1024-1024-1024---1024-32256
K21281024 32 1285121024128256 64 256--256102416256
P. stuartii
ATCC29916 64 512 16 128256512128512 64 256--5125128128
NEA161024-1024--------1024-64256
PS2636 32 512 64 128512-256256128512--512-32256
PS2996451281024128-128512256512128512--51251232256
P. aeruginosa
PA0151210245125125125121024512-1024-512102432256
PA124---------1024-64>256

- - : MIC and MBC not detected at up to 1024 μg/mL, Values in bold represent significant antibacterial activity of the plant extract

Minimal inhibitory concentration (MIC) and minimal bactericidal (MBC) of the plant extracts and CHL on the studied bacterial species - - : MIC and MBC not detected at up to 1024 μg/mL, Values in bold represent significant antibacterial activity of the plant extract

Antibacterial activity of the extracts in the presence of an Efflux Pumps Inhibitors

In the present work, extracts were combined with PAβN; However, no significant increase of the activities of the tested plant extracts was generally observed. Only AGL showed 4 times decrease of MICs against E. coli AG102 and E. cloacae BM67. In contrast, PAβN significantly improved the activity of the reference drug, CHL (more than 16 times) on MDR bacteria used (Table 5).
Table 5

MIC of the samples in the absence and presence of PAβN on the selected MDR bacterial species

MDR Bacteria used Samples and MIC (μg/mL)
Allanblackia gabonensis Gladiolus quartinianus (GQW) Combretum molle (CML) chloramphenicol
Flowers (AGFl)Fruits (AGF)Leaves (AGL)Stem bark (AGB)Root barks (AGR)
Alone+ PAβNalone+ PAβNAlone+ PAβNalone+ PAβNAlone+ PAβNAlone+ PAβNAlone+ PAβNAlone+ PAβN
E. coli
AG100ATet 102410241024512--1024102410241024--10241024 64 ≤2
AG102102410241024512 - 512 102410241241024--10241024 32 ≤2
E. aerogenes
CM64--10241024--------10241024 256 16
EA2891024102410241024-1024--10241024--1024512 128 8
E. cloacae
ECCI69--10241024---------->256128
BM67-1024-- - 512 ------10241024 >256 32
K. pneumoniae
K24-102410241024--1024102410241024--10241024 32 2
P. stuartii -
NEA16--10241024---1024-1024--10241024 64 8
P. aeruginosa
PA124------------10241024 64 8
MIC of the samples in the absence and presence of PAβN on the selected MDR bacterial species

Antibiotic resistance modifying activities of the plant extracts

Tables 2, 6 and 7 highlights the potentiating effects of the extracts on the activity of eight commonly used antibiotics. The most important modulating effects were observed of association CML with aminoglycosides (kanamycin and streptomycin), the potentiation effects varying from 77.78 to 88.89 % and from 66.67 to 77.78 % at MIC/2 and MIC/4 respectively; and with tetracycline (100 % and 77.78 % at MIC/2 and MIC/4 respectively) (Table 6). The modulating effects also ranged between 50 to 67 %, with the extract from A. gabonensis fruits (AGF) when combined at (MIC/2) with the some antibiotics. At MIC/4, AGF showed synergy less than 50 % on the tested bacteria with all antibiotics (Table 7). The most significant increases of antibiotic activity in the presence of plant extracts were noted with the association of streptomycin and CML and AGF on E. coli AG100ATet, with more than 128 fold and 64-fold decreases of MIC respectively. No increase of activity was noted with ampicillin, a β-lactamine when it was combined with plant extracts.
Table 6

Resistance modulating effect of the methanol leaves extract from Combretum molle at its sub-inhibitory concentrations on selected

Antibiotics a Extract concentrations MDR Bacteria used % Modulating effect b
E. coli E. aerogenes K. pneumoniae P. stuartii P. aeruginosa
AG100 AG102 AG100 Tet CM64 EA289 EA298 K24 NEA16 PA124
AMP0---------
MIC/2-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)0
MIC/4-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)0
CHL08326425612864646464
MIC/28(1)16 (2)32(2)256(1)64(2)8(8)64(1)16(4)32(2) 66.65
MIC/48(1)32(1)64(1)256(1)64(2)32(2)64(1)32(2)32(2)44.44
CIP0≤0.5≤0.5128641281128132
MIC/2≤0.5(NA)≤0.564(2)64(1)128(1)1(1)64(2)1(1)16(2)33.33
MIC/4≤0.5(NA)≤0.564(2)64(1)128(1)1(1)64(2)1(1)16(2)33.33
NFX0≤0.5≤0.5256-1288-4128
MIC/2≤0.5(NA)≤0.5128(2)64(>4)128(1)8(1)-(NA)4(1)64(2)33.33
MIC/4≤0.5(NA)≤0.5256(1)64(>4)128(1)8(1)-(NA)4(1)64(2)22.22
KAN 0644821632416128
MIC/24(16)4(1)4(2)≤0.5(>4)2(8)32(1)2(2)4(4)64(2) 77.78
MIC/48(8)4(1)4(2)1(2)4(4)32(1)2(2)8(2)64(2) 77.78
STR 0>64--4163243264
MIC/2>64(NA)256 (≥2) 4(>64)1(4)4(4)16(2)1(4)8(4)32(2) 88.89
MIC/4>64(NA)-128(>2)2(2)4(4)32(1)2(2)16(2)32(2) 66.67
ERY03264 - -641612816128
MIC/28(4)64(1)256(>1)-(NA)64(1)4(4)128(1)4(4)64(2)44.44
MIC/48(4)64(1)-(NA)-(NA)64(1)16(1)128(1)8(2)128(1)22.22
TET 028321632416416
MIC/2≤0.5(>4)2(4)8(4)4(4)8(4)2(2)8(2)2(2)4(4) 100
MIC/41(2)8(1)32(1)8(2)8(4)2(2)8(2)2(2)4(4) 77.78

: Antibiotics (TET: tetracycline, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin; - : MIC not detected at up to 256 μg/mL; (): Modulation factor or gain of activity; : Percentage of Antibiotic’s modulation Activity by the Plant extracts; Indications in bold represent the modulation factor ≥ 2, antibiotics having a percentage of modulating effect greather than 50 %; NA: Not applicable

Table 7

Resistance modulating effect of the Fruits methanol extract from Allanblackia gabonensis at its sub-inhibitory concentrations on selected MDR bacteria

Antibiotics a Extract concentrations MDR Bacteria used % Modulating effect b
E. coli E. aerogenes K. pneumoniae P. stuartii P. aeruginosa
AG100 AG102 AG100A Tet CM64 EA289 EA298 K24 NEA16 PA124
AMP0---------
MIC/2-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)0
MIC/4-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)-(NA)0
CHL08326425612864646464
MIC/28(1)32(1)64(1)256(1)128(1)32(2) 32(2)64(1)32(2)33.33
MIC/48(1)32(1)64(1)256(1)128(1)64(1)64(1)64(1)64(1)0
CIP0≤0.5≤0.5128641281128132
MIC/2≤0.5(NA)≤0.5(NA)64(2)32(2) 128(1)2(0.5)128(1)1(1)32(1)33.33
MIC/4≤0.5(NA)≤0.5(NA)64(2)64(1)128(1)2(0.5)128(1)1(1)32(1)11.11
NFX0≤0.5≤0.5256-1288-4128
MIC/21(≤0.5)≤0.5(NA)256(1)128(>2)128(1)8(1)-(NA)4(1)128(1)11.11
MIC/41(≤0.5)≤0.5(NA)256(1)-(NA)128(1)8(1)-(NA)4(1)128(1)0
KAN 0644821632416128
MIC/22(32)4(1)2(4)≤0.5(≥4)1(16)32(1)2(2)16(1)64(2) 66.67
MIC/44(16)4(1)4(2)2(1)4(4)32(1)4(1)16(1)64(2)44.44
STR 0>64--4163243264
MIC/2>64(NA)-(NA)2(>128)2(2)2(8)32(1)4(1)16(2)32(2) 55.56
MIC/4>64(NA)-(NA)8(>32)2(2)4(4)32(1)4(1)32(1)32(2) 44.44
ERY03264--641612816128
MIC/216(2)64(1)256(>1)-(NA)64(1)16(1)128(1)16(1)128(1)11.11
MIC/416(2)64(1)-(NA)-(NA)64(1)16(1)128(1)16(1)128(1)0
TET 028321632416416
MIC/21(2)4(2) 8(4)4(4)4(8)4(1)16(1)2(2)16(1) 66.67
MIC/41(2)8(1)8(4) 4(4)8(4)4(1)16(1)4(1)16(1)44.44

: Antibiotics (TET: tetracycline, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin; - : MIC not detected at up to 256 μg/mL; (): Modulation factor or gain of activity; : Percentage of antibiotic’s modulation activity by the Plant extracts; Indications in bold represent the modulation factor ≥ 2 and antibiotics having a percentage of modulating effect greather than 50 %; NA: Not applicable

Resistance modulating effect of the methanol leaves extract from Combretum molle at its sub-inhibitory concentrations on selected : Antibiotics (TET: tetracycline, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin; - : MIC not detected at up to 256 μg/mL; (): Modulation factor or gain of activity; : Percentage of Antibiotic’s modulation Activity by the Plant extracts; Indications in bold represent the modulation factor ≥ 2, antibiotics having a percentage of modulating effect greather than 50 %; NA: Not applicable Resistance modulating effect of the Fruits methanol extract from Allanblackia gabonensis at its sub-inhibitory concentrations on selected MDR bacteria : Antibiotics (TET: tetracycline, KAN: kanamycin, STR: streptomycin, ERY: erythromycin, CHL: chloramphenicol, NFX: norfloxacin, CIP: ciprofloxacin, AMP: ampicillin; - : MIC not detected at up to 256 μg/mL; (): Modulation factor or gain of activity; : Percentage of antibiotic’s modulation activity by the Plant extracts; Indications in bold represent the modulation factor ≥ 2 and antibiotics having a percentage of modulating effect greather than 50 %; NA: Not applicable

Discussion

Medicinal plants are potential source of antimicrobial agents used in the treatment of infectious diseases [43, 44]. According to Kuete et al. [45, 46], the antibacterial activity of a plant extract is considered significant when the MICs are below 100 μg/mL, moderate when 100 ≤ MIC ≤ 625 μg/mL and weak when MIC are above 625 μg/mL. Consequently, the antibacterial activities of the tested extracts particularly those from A. gabonensis (AGF, AGR, AGB and AGFl) and C. molle (CML) were generally moderated (Table 4). Significant activities were recorded with AGF, AGR, AGB, and AGFl respectively on 37.93 %, 24.14 %, 20.70 % and 17.24 %. This highlights the good antibacterial potential of the tested extracts. The overall activity recorded with most of the studied extracts could be considered significant, especially those from A. gabonensis and C. molle [47]. When analyzing carefully the MIC and MBC results for the extract, it can be noted that MBC ≤ 4 were obtained with these samples on most of the tested bacterial species, suggesting their killing effects [48]. PAβN is a potent inhibitor of RND systems like AcrAB-TolC in Enterobacteriaceae or MexAB-OprM in P. aeruginosa used in the present work [49, 50]; The activity observed when chloramphenicol was tested in the presence of PAβN increased significantly, confirming that the tested bacteria are good models of efflux pumps-expressing bacteria. Reversal of multi-drug resistance appears today as another attempt to mitigate the spread of resistance in bacteria. In recent years, many plants extracts and secondary metabolites have been evaluated as modulators of the antibiotic activity in efflux pumps in MDR bacteria [9–11, 37, 51–54]. Herein, we demonstrated that a beneficial effect of the combination of the extracts from the leaves of C. molle (CML) and fruits of A. gabonensis (AGF) with CHL, KAN and STR could be achieved. Synergistic or modulating effects of the plant extracts particularly C. molle extract with antibiotics were noted on more than 70 % of the tested MDR bacteria, suggesting that some of their constituents can act as efflux pump inhibitors [51]. These constituents might act by blocking the efflux pumps located in the cell membrane in the tested bacteria, preventing the extrusion of antibiotics in the cytoplasm and therefore restoring their activity as observed in this study [55, 56]. This is the first time to report the potential of the studied extracts, particularly those from the leaves of C. molle (CML) and the fruits of A. gabonensis (AGF) to reverse antibiotic resistance in MDR bacteria.

Conclusion

This study provides informative data on the antimicrobial potential of the tested plant extracts and suggests that extracts from Allanblackia gabonensis could be a source of natural antibacterial products whilst Combretum molle leaves extract could contain both antibacterial substances and antibiotic-modulation agents. These data indicate that these plants can be used to fight bacterial infections and especially those involving MDR phenotypes.
  40 in total

1.  Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone.

Authors:  Victor Kuete; Bathélémy Ngameni; Jean G Tangmouo; Jean-Michel Bolla; Sandrine Alibert-Franco; Bonaventure T Ngadjui; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

Review 2.  Potential of Cameroonian plants and derived products against microbial infections: a review.

Authors:  Victor Kuete
Journal:  Planta Med       Date:  2010-06-08       Impact factor: 3.352

3.  Efflux pumps of gram-negative bacteria, a new target for new molecules.

Authors:  Jean-Marie Pagès; Alibert-Franco Sandrine; Abdallah Mahamoud; Jean-Michel Bolla; Anne Davin-Regli; Jacqueline Chevalier; Eric Garnotel
Journal:  Curr Top Med Chem       Date:  2010       Impact factor: 3.295

Review 4.  Bacterial efflux pump inhibitors from natural sources.

Authors:  Michael Stavri; Laura J V Piddock; Simon Gibbons
Journal:  J Antimicrob Chemother       Date:  2006-12-04       Impact factor: 5.790

Review 5.  Practical applications and feasibility of efflux pump inhibitors in the clinic--a vision for applied use.

Authors:  Olga Lomovskaya; Keith A Bostian
Journal:  Biochem Pharmacol       Date:  2006-01-19       Impact factor: 5.858

Review 6.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

7.  Investigations on antimycobacterial activity of some Ethiopian medicinal plants.

Authors:  K Asres; F Bucar; S Edelsbrunner; T Kartnig; G Höger; W Thiel
Journal:  Phytother Res       Date:  2001-06       Impact factor: 5.878

8.  Analgesic and antiinflammatory effects of mollic acid glucoside, a 1 alpha-hydroxycycloartenoid saponin extractive from Combretum molle R. Br. ex G. Don (Combretaceae) leaf.

Authors:  John A O Ojewole
Journal:  Phytother Res       Date:  2008-01       Impact factor: 5.878

Review 9.  Antibacterial resistance: current problems and possible solutions.

Authors:  Rashmi Sharma; Chaman Lal Sharma; Bhuvneshwar Kapoor
Journal:  Indian J Med Sci       Date:  2005-03

10.  Antibacterial activities of selected Cameroonian spices and their synergistic effects with antibiotics against multidrug-resistant phenotypes.

Authors:  Aimé G Fankam; Victor Kuete; Igor K Voukeng; Jules R Kuiate; Jean-Marie Pages
Journal:  BMC Complement Altern Med       Date:  2011-11-01       Impact factor: 3.659

View more
  8 in total

1.  In vitro Antibacterial Activity of Combretum edwardsii, Combretum krausii, and Maytenus nemorosa and Their Synergistic Effects in Combination with Antibiotics.

Authors:  Jude C Chukwujekwu; Johannes van Staden
Journal:  Front Pharmacol       Date:  2016-07-15       Impact factor: 5.810

2.  Antibacterial activities of the methanol extract, fractions and compounds from Elaeophorbia drupifera (Thonn.) Stapf. (Euphorbiaceae).

Authors:  Igor K Voukeng; Blaise K Nganou; Louis P Sandjo; Ilhami Celik; Veronique P Beng; Pierre Tane; Victor Kuete
Journal:  BMC Complement Altern Med       Date:  2017-01-07       Impact factor: 3.659

3.  Antibacterial activities of the methanol extracts of Albizia adianthifolia, Alchornea laxiflora, Laportea ovalifolia and three other Cameroonian plants against multi-drug resistant Gram-negative bacteria.

Authors:  Cedric F Tchinda; Igor K Voukeng; Veronique P Beng; Victor Kuete
Journal:  Saudi J Biol Sci       Date:  2016-01-25       Impact factor: 4.219

4.  Antibacterial and antibiotic resistance modulatory activities of leaves and bark extracts of Recinodindron heudelotii (Euphorbiaceae) against multidrug-resistant Gram-negative bacteria.

Authors:  Aimé Gabriel Fankam; Jules-Roger Kuiate; Victor Kuete
Journal:  BMC Complement Altern Med       Date:  2017-03-24       Impact factor: 3.659

5.  Phytochemical screening, antimycobacterial activity and acute toxicity of crude extracts of selected medicinal plant species used locally in the treatment of tuberculosis in Uganda.

Authors:  Benson Oloya; Jane Namukobe; Willy Ssengooba; Mathias Afayoa; Robert Byamukama
Journal:  Trop Med Health       Date:  2022-02-17

6.  Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.

Authors:  Jackson A Seukep; Louis P Sandjo; Bonaventure T Ngadjui; Victor Kuete
Journal:  BMC Complement Altern Med       Date:  2016-07-07       Impact factor: 3.659

7.  Resensitization of Fluconazole-Resistant Urinary Candida spp. Isolates by Amikacin through Downregulation of Efflux Pump Genes.

Authors:  Eva A Edward; Nelly M Mohamed; Azza S Zakaria
Journal:  Pol J Microbiol       Date:  2020-03-11

8.  Antibacterial and Antibiotic-Potentiating Activities of Thirteen Cameroonian Edible Plants against Gram-Negative Resistant Phenotypes.

Authors:  Paul Nayim; Armelle T Mbaveng; Brice E N Wamba; Aimé G Fankam; Joachim K Dzotam; Victor Kuete
Journal:  ScientificWorldJournal       Date:  2018-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.